NASDAQ:TRIB Trinity Biotech - TRIB Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trinity Biotech plc Please log in to your account or sign up in order to add this asset to your watchlist. $0.94 +0.02 (+2.17%) (As of 03/31/2023 12:00 AM ET) Add Compare Share Share Today's Range$0.89▼$0.9450-Day Range$0.87▼$1.1852-Week Range$0.84▼$1.55Volume19,710 shsAverage Volume30,368 shsMarket Capitalization$35.82 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Trinity Biotech MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.10% of Shares Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.19) to $0.19 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.23 out of 5 starsMedical Sector973rd out of 1,004 stocksDiagnostic Substances Industry13th out of 14 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Trinity Biotech. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.10% of the outstanding shares of Trinity Biotech have been sold short.Short Interest Ratio / Days to CoverTrinity Biotech has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Trinity Biotech has recently increased by 10.88%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldTrinity Biotech does not currently pay a dividend.Dividend GrowthTrinity Biotech does not have a long track record of dividend growth.Dividend SustainabilityBased on EPS estimates, Trinity Biotech will have a dividend payout ratio of 115.79% in the coming year. This indicates that Trinity Biotech may not be able to sustain their current dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TRIB. Previous Next 3.1 News and Social Media Coverage News SentimentTrinity Biotech has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Trinity Biotech this week, compared to 0 articles on an average week.MarketBeat Follows1 people have added Trinity Biotech to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Trinity Biotech insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.20% of the stock of Trinity Biotech is held by insiders.Percentage Held by InstitutionsOnly 18.41% of the stock of Trinity Biotech is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Trinity Biotech are expected to grow in the coming year, from ($0.19) to $0.19 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Trinity Biotech is -0.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Trinity Biotech is -0.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About Trinity Biotech (NASDAQ:TRIB) StockTrinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.Read More Receive TRIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address TRIB Stock News HeadlinesMarch 31, 2023 | americanbankingnews.comTrinity Biotech (NASDAQ:TRIB) Coverage Initiated at StockNews.comMarch 25, 2023 | finance.yahoo.comWhat Is Trinity Biotech plc's (NASDAQ:TRIB) Share Price Doing?April 1, 2023 | Legacy Research (Affiliate) (Ad)Sell every Stock except ONE Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...March 23, 2023 | finance.yahoo.comTrinity Biotech Announces Fourth Quarter and Fiscal Year 2022 Financial ResultsMarch 22, 2023 | marketwatch.comTrinity Biotech Welcomes TrinScreen HIV's Inclusion In The New Kenyan HIV Testing AlgorithmMarch 22, 2023 | finance.yahoo.comTrinity Biotech Welcomes TrinScreen HIV’s Inclusion In The New Kenyan HIV Testing AlgorithmMarch 22, 2023 | americanbankingnews.comTrinity Biotech (NASDAQ:TRIB) Coverage Initiated by Analysts at StockNews.comMarch 22, 2023 | americanbankingnews.comTrinity Biotech (TRIB) Scheduled to Post Quarterly Earnings on ThursdayApril 1, 2023 | Vantage Point (Ad)What’s At Stake In April is ShockingThe Fed will be meeting on a topic that could change trading forever, and the decision could come as soon as the end of April. But by taking the smartest approach now, you can help shield your assets and work toward your trading goals. Time, as always, is of the essence. Click on this link to see what you need to do right away. March 21, 2023 | techcrunch.comThis VC built a lab to make building biotech startups easierMarch 16, 2023 | finance.yahoo.comTrinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2022 Financial ResultsFebruary 23, 2023 | msn.comTrinity International to scrap in-person undergraduate programs in favor of online classesFebruary 22, 2023 | finance.yahoo.comTrinity Biotech Announces Entry Into An Increased Loan Facility to Fund Potential AcquisitionsFebruary 9, 2023 | businessinsider.comA biotech millionaire claimed his wild routine cut his biological age by 5 years. Scientists aren't sure most of it really works.January 9, 2023 | wsj.comTrinity Biotech Announces Strategic Partnership with imaware(TM) to Deliver Integrated Diagnostic Testing Solutions to Digital Health IndustryJanuary 9, 2023 | finance.yahoo.comTrinity Biotech Announces Strategic Partnership with imaware™ to Deliver Integrated Diagnostic Testing Solutions to Digital Health IndustryDecember 23, 2022 | msn.comEuropean Equities Rise Modestly in Friday Trading, End Week Up 1%December 22, 2022 | finance.yahoo.comTrinity Biotech plc (NASDAQ:TRIB) Q2 2022 Earnings Call TranscriptDecember 22, 2022 | finance.yahoo.comTrinity Biotech plc (NASDAQ:TRIB) Q3 2022 Earnings Call TranscriptDecember 16, 2022 | markets.businessinsider.comHere's what Wall Street expects from Trinity Biotech's earningsDecember 15, 2022 | seekingalpha.comTrinity Biotech plc (TRIB) Q3 2022 Earnings Call TranscriptDecember 15, 2022 | finance.yahoo.comTrinity Biotech Announces Q3 2022 Financial ResultsDecember 14, 2022 | msn.comTrinity Biotech's Earnings: A PreviewDecember 9, 2022 | finance.yahoo.comTrinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Financial ResultsDecember 9, 2022 | finance.yahoo.comTrinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Financial ResultsDecember 8, 2022 | msn.comPharma, Tech Sectors Help Buoy American Depositary Receipts of European StocksDecember 7, 2022 | msn.comPharama Stocks Nudge European Equities Modestly Higher in Wednesday TradingSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive TRIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address TRIB Company Calendar Last Earnings5/24/2021Today4/01/2023Next Earnings (Estimated)6/29/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Diagnostic substances Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TRIB CUSIPN/A CIK888721 Webwww.trinitybiotech.com Phone(531) 276-9800Fax353-1276-9888Employees543Year Founded1992Profitability EPS (Most Recent Fiscal Year)($1.29) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-41,010,000.00 Net Margins-54.84% Pretax Margin-55.09% Return on Equity-724.07% Return on Assets-25.12% Debt Debt-to-Equity Ratio8.70 Current Ratio2.69 Quick Ratio1.78 Sales & Book Value Annual Sales$74.78 million Price / Sales0.48 Cash FlowN/A Price / Cash FlowN/A Book Value($0.02) per share Price / Book-47.00Miscellaneous Outstanding Shares38,108,000Free Float34,983,000Market Cap$35.82 million OptionableOptionable Beta1.43 Social Links Key ExecutivesAris KekedjianChairman & Chief Executive OfficerJohn GillardCFO, Secretary & Executive DirectorEibhlin KellyChief Information OfficerTerence DunneDirector-Business DevelopmentFernando DeviaExecutive Vice President-SalesKey CompetitorsNymox PharmaceuticalNASDAQ:NYMXBiomericaNASDAQ:BMRAOncoCyteNASDAQ:OCXARCA biopharmaNASDAQ:ABIOImmuCellNASDAQ:ICCCView All CompetitorsInstitutional OwnershipStonehill Capital Management LLCSold 395,597 shares on 2/15/2023Ownership: 4.389%Susquehanna International Group LLPSold 14,000 shares on 2/14/2023Ownership: 0.000%Renaissance Technologies LLCSold 44,800 shares on 2/13/2023Ownership: 3.657%Atria Wealth Solutions Inc.Bought 9,600 shares on 2/13/2023Ownership: 0.090%Group One Trading L.P.Bought 17,500 shares on 2/9/2023Ownership: 0.000%View All Institutional Transactions TRIB Stock - Frequently Asked Questions How have TRIB shares performed in 2023? Trinity Biotech's stock was trading at $0.99 at the beginning of the year. Since then, TRIB shares have decreased by 5.1% and is now trading at $0.94. View the best growth stocks for 2023 here. When is Trinity Biotech's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, June 29th 2023. View our TRIB earnings forecast. How were Trinity Biotech's earnings last quarter? Trinity Biotech plc (NASDAQ:TRIB) announced its earnings results on Monday, May, 24th. The company reported $0.10 earnings per share for the quarter, topping analysts' consensus estimates of $0.07 by $0.03. The business earned $25.59 million during the quarter. Trinity Biotech had a negative trailing twelve-month return on equity of 724.07% and a negative net margin of 54.84%. Is Trinity Biotech a good dividend stock? Trinity Biotech (NASDAQ:TRIB) pays an annual dividend of $0.22 per share and currently has a dividend yield of 0.00%. Read our dividend analysis for TRIB. What is Ronan O'Caoimh's approval rating as Trinity Biotech's CEO? 20 employees have rated Trinity Biotech Chief Executive Officer Ronan O'Caoimh on Glassdoor.com. Ronan O'Caoimh has an approval rating of 8% among the company's employees. This puts Ronan O'Caoimh in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Trinity Biotech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Trinity Biotech investors own include Gilead Sciences (GILD), Novavax (NVAX), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Netflix (NFLX), Pfizer (PFE), QUALCOMM (QCOM), Energy Transfer (ET) and Exxon Mobil (XOM). What is Trinity Biotech's stock symbol? Trinity Biotech trades on the NASDAQ under the ticker symbol "TRIB." How do I buy shares of Trinity Biotech? Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Trinity Biotech's stock price today? One share of TRIB stock can currently be purchased for approximately $0.94. How much money does Trinity Biotech make? Trinity Biotech (NASDAQ:TRIB) has a market capitalization of $35.82 million and generates $74.78 million in revenue each year. The company earns $-41,010,000.00 in net income (profit) each year or ($1.29) on an earnings per share basis. How many employees does Trinity Biotech have? The company employs 543 workers across the globe. How can I contact Trinity Biotech? Trinity Biotech's mailing address is IDA BUSINESS PARK BRAY, WICKLOW L2, . The official website for the company is www.trinitybiotech.com. The company can be reached via phone at (531) 276-9800, via email at kevin.tansley@trinitybiotech.com, or via fax at 353-1276-9888. This page (NASDAQ:TRIB) was last updated on 4/1/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.